These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35261120)

  • 1. Vaginal misoprostol and intravenous oxytocin for success of termination in the second-trimester intrauterine fetal demise: A randomized controlled clinical trial.
    Asadi N; Vafaei H; Hessami K; Darabi MH; Kasraeian M; Faraji A; Alavi A; Abdi N; Gissuei A; Roozmeh S; Bazrafshan K; Gharibpour F
    J Obstet Gynaecol Res; 2022 Apr; 48(4):966-972. PubMed ID: 35261120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: A randomized clinical trial.
    Abediasl Z; Sheikh M; Pooransari P; Farahani Z; Kalani F
    J Obstet Gynaecol Res; 2016 Mar; 42(3):246-51. PubMed ID: 26663590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy.
    Zangeneh M; Malek-Khosravi S; Veisi F; Rezavand N; Rezaee M; Rajatee M
    Int J Gynaecol Obstet; 2012 Apr; 117(1):78-80. PubMed ID: 22261129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Misoprostol for termination of pregnancy with intrauterine fetal demise in the second and third trimester of pregnancy - a systematic review.
    Gómez Ponce de León R; Wing DA
    Contraception; 2009 Apr; 79(4):259-71. PubMed ID: 19272495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
    Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
    Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose vaginal misoprostol in the management of intrauterine fetal death.
    El-Gharib MN; Elebyary MT
    J Matern Fetal Neonatal Med; 2011 Oct; 24(10):1239-42. PubMed ID: 21714693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal misoprostol versus combined intracervical foley's catheter and oxytocin infusion for second trimester pregnancy termination in women with previous caesarean sections: a randomised control trial.
    Elasy AN; Ibrahem MA; Elhawy LL; Hamed BM
    J Obstet Gynaecol; 2022 Oct; 42(7):2962-2969. PubMed ID: 36149628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial.
    Wong KS; Ngai CS; Wong AY; Tang LC; Ho PC
    Contraception; 1998 Oct; 58(4):207-10. PubMed ID: 9866000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
    Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial comparing isosorbide dinitrate-oxytocin versus misoprostol-oxytocin at management of foetal intrauterine death.
    Arteaga-Troncoso G; Chacon-Calderon AE; Martinez-Herrera FJ; Cruz-Nuñez SG; Lopez-Hurtado M; Belmont-Gomez A; Guzman-Grenfell AM; Farfan-Labonne BE; Neri-Méndez CJ; Zea-Prado F; Guerra-Infante FM
    PLoS One; 2019; 14(11):e0215718. PubMed ID: 31751343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol in second and early third trimester for termination of pregnancies with fetal anomalies.
    Mendilcioglu I; Simsek M; Seker PE; Erbay O; Zorlu CG; Trak B
    Int J Gynaecol Obstet; 2002 Nov; 79(2):131-5. PubMed ID: 12427397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial.
    Wong KS; Ngai CS; Yeo EL; Tang LC; Ho PC
    Hum Reprod; 2000 Mar; 15(3):709-12. PubMed ID: 10686224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine rupture associated with the use of intra-vaginal misoprostol during second-trimester pregnancy termination.
    Syed S; Noreen H; Kahloon LE; Chaudhri R
    J Pak Med Assoc; 2011 Apr; 61(4):399-401. PubMed ID: 21465985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial.
    Tanha FD; Golgachi T; Niroomand N; Ghajarzadeh M; Nasr R
    Arch Gynecol Obstet; 2013 Jan; 287(1):65-9. PubMed ID: 22903515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misoprostol for induction of labour to terminate pregnancy in the second or third trimester for women with a fetal anomaly or after intrauterine fetal death.
    Dodd JM; Crowther CA
    Cochrane Database Syst Rev; 2010 Apr; 2010(4):CD004901. PubMed ID: 20393941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misoprostol versus cervagem for the induction of labour to terminate pregnancy in the second and third trimester: a systematic review.
    Dodd JM; Crowther CA
    Eur J Obstet Gynecol Reprod Biol; 2006 Mar; 125(1):3-8. PubMed ID: 16466671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.